OXOlife

Developer of a reproductive drug designed to enhance female fertility. The company's drug acts directly on the endometrium to enhance embryo implantation and restore ovulation, enabling clinicians to enhance female fertility success.

Overview Structured Data Issues Contributors

oxolife.com

Is a

Company

Organization

Company attributes

Industry

Location

Pitchbook URL

pitchbook.com/profiles...436026-97

Accelerator

BStartup

Number of Employees (Ranges)

1 – 10

Email Address

Number of Employees

Full Address

C/ Baldiri Reixac, 4-8 (08028) Barcelona, Spain0

Investors

BStartup

Founded Date

2013

Total Funding Amount (USD)

121,560

Latest Funding Round Date

January 28, 2021

Latest Funding Type

‌

Venture round

Country

Spain

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

121,560

Public/Private

Private0

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like OXOlife

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.